Literature DB >> 17071736

Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells.

Lioubov I Brueggemann1, Christopher J Moran, John A Barakat, Jay Z Yeh, Leanne L Cribbs, Kenneth L Byron.   

Abstract

[Arg(8)]-vasopressin (AVP), at low concentrations (10-500 pM), stimulates oscillations in intracellular Ca(2+) concentration (Ca(2+) spikes) in A7r5 rat aortic smooth muscle cells. Our previous studies provided biochemical evidence that protein kinase C (PKC) activation and phosphorylation of voltage-sensitive K(+) (K(v)) channels are crucial steps in this process. In the present study, K(v) currents (I(Kv)) and membrane potential were measured using patch clamp techniques. Treatment of A7r5 cells with 100 pM AVP resulted in significant inhibition of I(Kv). This effect was associated with gradual membrane depolarization, increased membrane resistance, and action potential (AP) generation in the same cells. The AVP-sensitive I(Kv) was resistant to 4-aminopyridine, iberiotoxin, and glibenclamide but was fully inhibited by the selective KCNQ channel blockers linopirdine (10 microM) and XE-991 (10 microM) and enhanced by the KCNQ channel activator flupirtine (10 microM). BaCl(2) (100 microM) or linopirdine (5 microM) mimicked the effects of AVP on K(+) currents, AP generation, and Ca(2+) spiking. Expression of KCNQ5 was detected by RT-PCR in A7r5 cells and freshly isolated rat aortic smooth muscle. RNA interference directed toward KCNQ5 reduced KCNQ5 protein expression and resulted in a significant decrease in I(Kv) in A7r5 cells. I(Kv) was also inhibited in response to the PKC activator 4beta-phorbol 12-myristate 13-acetate (10 nM), and the inhibition of I(Kv) by AVP was prevented by the PKC inhibitor calphostin C (250 nM). These results suggest that the stimulation of Ca(2+) spiking by physiological concentrations of AVP involves PKC-dependent inhibition of KCNQ5 channels and increased AP firing in A7r5 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071736      PMCID: PMC2577603          DOI: 10.1152/ajpheart.00065.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  60 in total

Review 1.  Chloride channels and their functional roles in smooth muscle tone in the vasculature.

Authors:  K Kitamura; J Yamazaki
Journal:  Jpn J Pharmacol       Date:  2001-04

Review 2.  KCNQ potassium channels: physiology, pathophysiology, and pharmacology.

Authors:  J Robbins
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

3.  Mitogenic modulation of Ca2+ -activated K+ channels in proliferating A7r5 vascular smooth muscle cells.

Authors:  Han Si; Ivica Grgic; Willm-Thomas Heyken; Tanja Maier; Joachim Hoyer; Hans-Peter Reusch; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

4.  Role of Cl- current in endothelin-1-induced contraction in rabbit basilar artery.

Authors:  Y Dai; J H Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-11       Impact factor: 4.733

Review 5.  Ion channels and vascular tone.

Authors:  W F Jackson
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

6.  Inhibition of voltage-gated K(+) currents by endothelin-1 in human pulmonary arterial myocytes.

Authors:  L A Shimoda; J T Sylvester; G M Booth; T H Shimoda; S Meeker; B J Undem; J S Sham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

7.  Ca2+ signalling in rat vascular smooth muscle cells: a role for protein kinase C at physiological vasoconstrictor concentrations of vasopressin.

Authors:  J Fan; K L Byron
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

8.  Expression and function of native potassium channel [K(V)alpha1] subunits in terminal arterioles of rabbit.

Authors:  A Cheong; A M Dedman; D J Beech
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

9.  Ca(2+)-activated Cl- and K+ channels and their modulation by endothelin-1 in rat pulmonary arterial smooth muscle cells.

Authors:  K J Salter; J L Turner; S Albarwani; L H Clapp; R Z Kozlowski
Journal:  Exp Physiol       Date:  1995-09       Impact factor: 2.969

10.  Pulmonary vasoconstrictor action of KCNQ potassium channel blockers.

Authors:  Shreena Joshi; Prabhu Balan; Alison M Gurney
Journal:  Respir Res       Date:  2006-02-20
View more
  36 in total

1.  Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.

Authors:  Lioubov I Brueggemann; Priyanka P Kakad; Robert B Love; Julian Solway; Maria L Dowell; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

Review 2.  Nano-Bioelectronics.

Authors:  Anqi Zhang; Charles M Lieber
Journal:  Chem Rev       Date:  2015-12-21       Impact factor: 60.622

3.  Kv7.2 regulates the function of peripheral sensory neurons.

Authors:  Chih H King; Eric Lancaster; Daniela Salomon; Elior Peles; Steven S Scherer
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

4.  Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

Authors:  Kyle K Henderson; Kenneth L Byron
Journal:  J Appl Physiol (1985)       Date:  2007-01-04

5.  Diclofenac distinguishes among homomeric and heteromeric potassium channels composed of KCNQ4 and KCNQ5 subunits.

Authors:  Lioubov I Brueggemann; Alexander R Mackie; Jody L Martin; Leanne L Cribbs; Kenneth L Byron
Journal:  Mol Pharmacol       Date:  2010-09-28       Impact factor: 4.436

6.  Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.

Authors:  Thomas A Jepps; Iain A Greenwood; James D Moffatt; Kenton M Sanders; Susumu Ohya
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

7.  Kv7 (KCNQ) potassium channels that are mutated in human diseases.

Authors:  David A Brown
Journal:  J Physiol       Date:  2008-04-01       Impact factor: 5.182

Review 8.  New tricks for old dogs: KCNQ expression and role in smooth muscle.

Authors:  Iain A Greenwood; Susumu Ohya
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

9.  Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.

Authors:  L V Fretwell; J Woolard
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles.

Authors:  Lioubov I Brueggemann; Alexander R Mackie; Bharath K Mani; Leanne L Cribbs; Kenneth L Byron
Journal:  Mol Pharmacol       Date:  2009-07-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.